Indo US Bio-Tech standalone net profit rises 33.76% in the June 2024 quarter

Net profit of Indo US Bio-Tech rose 33.76% to Rs 3.17 crore in the quarter ended June 2024 as against Rs 2.37 crore during the previous quarter ended June 2023. Sales rose 29.15% to Rs 24.72 crore in the quarter ended June 2024 as against Rs 19.14 crore during the previous quarter ended June 2023.

Particulars	Quarter Ended
	Jun. 2024	Jun. 2023	% Var.
Sales	24.72	19.14	29
OPM %	14.93	15.62	-
PBDT	3.39	2.65	28
PBT	3.19	2.45	30
NP	3.17	2.37	34